Tetrahydroquinoline derivatives as CRTH2 antagonists
摘要:
A series of tetrahydroquinoline-derived inhibitors of the CRTH2 receptor was discovered by a high throughput screen. Optimization of these compounds for potency and pharmacokinetic properties led to the discovery of potent and orally bioavailable CRTH2 antagonists. (C) 2009 Elsevier Ltd. All rights reserved.
The invention relates to compounds of formula (I)
wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
and R
8
are as defined in the description, their use as medicament, pharmaceutical compositions containing them and processes for their preparation.
TETRAHYDROQUINOLINE DERIVATIVES AS CRTH2 ANTAGONISTS
申请人:Warner-Lambert Company LLC
公开号:EP1556356A1
公开(公告)日:2005-07-27
US7220760B2
申请人:——
公开号:US7220760B2
公开(公告)日:2007-05-22
[EN] TETRAHYDROQUINOLINE DERIVATIVES AS CRTH2 ANTAGONISTS<br/>[FR] DERIVES DE TETRAHYDROQUINOLINE ANTAGONISTES DE CRTH2
申请人:WARNER LAMBERT CO
公开号:WO2004035543A1
公开(公告)日:2004-04-29
The invention relates to compounds of formula (I) wherein Rl, R2, R3, R4, R5, R6, R7 and R8 are as defined in the description, their use as medicament, pharmaceutical compositions containing them and processes for their preparation.
Tetrahydroquinoline derivatives as CRTH2 antagonists
A series of tetrahydroquinoline-derived inhibitors of the CRTH2 receptor was discovered by a high throughput screen. Optimization of these compounds for potency and pharmacokinetic properties led to the discovery of potent and orally bioavailable CRTH2 antagonists. (C) 2009 Elsevier Ltd. All rights reserved.